Top Mushroom Penny Stocks To Watch In September 2020

Should Mushroom Stocks Be Part Of Your Strategy In 2020?

Revive Therapeutics Enters into Clinical Trial Agreement to Evaluate Psilocybin for the Treatment of Methamphetamine Use Disorder

TORONTO, Sept. 02, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or…

Revive Therapeutics Advancing Drug Delivery Technology for Psychedelics

Developed Prototypes of Orally Dissolvable Thin Film For Psilocybin TORONTO, Aug. 11,…

A Blooming Opportunity For Investors To Cash In On Mushroom Stocks

Once A Fringe Industry Now Being Called The Biggest Opportunity Since Legal Cannabis

Revive Therapeutics Expands Research Partnership for Novel Formulation Development and Clinical Research of Psilocybin with the University of Wisconsin-Madison

TORONTO, June 12, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or…

Psychedelic Penny Stocks To Watch Amid The Mushroom Boom

Psilocybin, MDMA, Ayahuasca & Other “Mind Medicine” Are Propelling Psychedelic Stocks; Are…

3 Penny Stocks To Watch Under $1 Right Now

Penny Stocks Trading Under $1; Are They On Your List This Month?…